ArticleTrials2023

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.

Sibel Saya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.